Scientists at the Champalimo Foundation have identified a biomarker “more reliable for assessing and improving treatment” for pancreatic cancer, one of the deadliest, the institution announced this Thursday.
We are talking about the so-called extracellular vesicles, “mini-cells produced by almost all cells, including cancer cells.”
“If very aggressive cancers, such as pancreatic ductal adenocarcinoma, use extracellular vesicles to detoxify the immune system, we can develop new therapies that target tumor-derived extracellular vesicles, making these cancers less resistant to treatment,” he notes. . , is quoted in a statement by the Champalimo Foundation, led by Bruno Costa-Silva, who coordinates a laboratory dealing with biological systems that support cancer.
Author: Lusa
Source: CM Jornal
Jane Stock is a technology author, who has written for 24 Hours World. She writes about the latest in technology news and trends, and is always on the lookout for new and innovative ways to improve his audience’s experience.
